头颈部鳞癌双侧颈淋巴结选择性照射后对侧区域失败的发生率
该回顾性队列研究纳入2008至2017年接受原发(化)放疗及双侧颈部选择性淋巴结照射(ENI)的605例T1-4N0-3头颈部鳞状细胞癌(HNSCC)患者,中位随访43个月。结果显示3年区域失败(RF)累积发生率为12.7%,同侧RF(iRF)和对侧RF(cRF)分别为10.6%和2.8%,所有cRF均发生于选择性照射体积内,多因素分析未发现cRF的显著预测因素。
要点
- 双侧ENI后cRF罕见但仍有2.8%发生,均位于选择性照射体积内。
- iRF与cRF患者的挽救治疗可能性和生存率无显著差异。
- 多因素分析未识别出双侧ENI后cRF的显著预测因素。
核心结论
- 双侧ENI后对侧区域失败罕见,但仍有2.8%的患者发生cRF。
- cRF患者的挽救治疗可能性及总生存、癌症特异性生存与iRF患者相当。
研究设计与样本
- 回顾性队列研究,连续纳入605例T1-4N0-3 HNSCC患者,2008至2017年接受原发(化)放疗和双侧ENI。
- 中位随访43个月(范围1.4-126)。
主要发现
- 3年RF累积发生率为12.7%,iRF为10.6%,cRF为2.8%。
- 所有cRF均发生在选择性治疗体积内。
- iRF和cRF患者挽救治疗可能性分别为65%和59%(p=0.746)。
- RF后3年总生存率iRF为27.4%、cRF为41.2%(p=0.713)。
- 3年癌症特异性生存率iRF为31.6%、cRF为48.1%(p=0.634)。
关键数值与推荐
- 双侧ENI后3年cRF累积发生率为2.8%。
- 多因素分析未发现cRF的显著预测因素。
临床怎么用
- 双侧ENI后cRF发生率低,支持评估更选择性(如单侧ENI)方法时参考此基线。
- cRF后仍可行挽救治疗,生存与iRF相当,提示对侧选择性照射体积内复发需积极管理。
局限性
- 回顾性队列研究设计。
- 多因素分析未识别cRF显著预测因素,可能受事件数限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The vast majority of patients with head and neck squamous cell carcinoma (HNSCC) routinely undergo elective nodal irradiation (ENI) to both sides of the neck. Little is known about the extent to which bilateral ENI prevents regional failure (RF) and contralateral RF (cRF) in particular, while such knowledge is necessary to evaluate the results of more selective approaches like unilateral ENI. We investigated the rate and pattern of RF after bilateral ENI, the rate of cRF in the electively irradiated contralateral neck, and tried to identify risk factors for development of cRF. MATERIALS AND METHODS: Retrospective cohort study of a consecutive series of 605 patients with T1-4N0-3 HNSCC treated between 2008 and 2017 with primary (chemo)radiation and bilateral ENI. RESULTS: Median follow-up was 43 months (range 1.4-126). Three-year cumulative incidence of RF was 12.7%. Three-year cumulative incidences of ipsilateral RF (iRF) and cRF were 10.6% and 2.8%, respectively. All cRF occurred within the electively treated volume. Salvage treatment was possible in 65% and 59% of patients with iRF and cRF, respectively (p = 0.746). The 3-year overall survival rates after RF in patients with iRF and cRF were 27.4% and 41.2%, respectively (p = 0.713). Three-year cancer-specific survival rates were 31.6% and 48.1%, respectively (p = 0.634). In multivariate analysis, no significant predictive factors were identified for cRF after bilateral ENI. CONCLUSION: Contralateral regional failure is rare, but still occurs in 2.8% of patients treated with bilateral ENI. The possibilities for salvage treatment, the rates of overall survival and cancer-specific survival were comparable to patients with iRF.
引用
- de Veij Mestdagh PD, van Werkhoven E, Navran A, et al. Incidence of contralateral regional failure in the electively irradiated contralateral neck of patients with head and neck squamous cell carcinoma. Clin Transl Radiat Oncol. 2019. PMID: 31061901. doi:10.1016/j.ctro.2019.04.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。